Zobrazeno 1 - 10
of 30
pro vyhledávání: '"A. Mercier-Blas"'
Autor:
Romeo, Clémence, Joly, Florence, Ray-Coquard, Isabelle, El Kouri, Claude, Mercier-Blas, Anne, Berton-Rigaud, Dominique, Kalbacher, Elsa, Cojocarasu, Oana, Fabbro, Michel, Cretin, Jacques, Zannetti, Alain, Abadie-Lacourtoisie, Sophie, Mollon, Delphine, Hardy-Bessard, Anne-Claire, Provansal, Magali, Blot, Emmanuel, Delbaldo, Catherine, Lesoin, Anne, Freyer, Gilles, You, Benoît
Publikováno v:
In Gynecologic Oncology January 2019 152(1):68-75
Autor:
Marc Ychou, Michel Rivoire, Simon Thezenas, Rosine Guimbaud, Francois Ghiringhelli, Anne Mercier-Blas, Laurent Mineur, Eric Francois, Faiza Khemissa, Marion Chauvenet, Reza Kianmanesh, Marianne Fonck, Philippe Houyau, Thomas Aparicio, Marie-Pierre Galais, Franck Audemar, Eric Assenat, Evelyne Lopez-Crapez, Claire Jouffroy, Antoine Adenis, René Adam, Olivier Bouché
Publikováno v:
Br J Cancer
BACKGROUND: Colorectal cancer (CRC) patients have a better prognosis if metastases are resectable. Initially, unresectable liver-only metastases can be converted to resectable with chemotherapy plus a targeted therapy. We assessed which of chemothera
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sophie Abadie-Lacourtoisie, Claude El Kouri, Alain Zannetti, Catherine Delbaldo, Isabelle Ray-Coquard, J. Cretin, Elsa Kalbacher, Anne Mercier-Blas, Anne-Claire Hardy-Bessard, Dominique Berton-Rigaud, Emmanuel Blot, Anne Lesoin, Florence Joly, Delphine Mollon, Benoit You, Michel Fabbro, Clémence Romeo, Gilles Freyer, Oana Cojocarasu, Magali Provansal
Publikováno v:
Gynecologic oncology. 152(1)
Background Carboplatin and pegylated liposomal doxorubicin combination is a standard regimen in platinum-sensitive recurrent ovarian cancer patients. The pegylated liposomal doxorubicin shortage from 2011 to 2013 urged assessment of the efficacy and
Autor:
Christine Piprot-Choffat, Virginie Berger, Hélène Simon, Franck Priou, Philippe Bougnoux, Anne Mercier-Blas, Christelle Levy, Patrick Soulié, Jacques Bonneterre, Caroline Goupille
Publikováno v:
Cancer Research. 75:P3-13
Background: Long chain n-3 Polyunsaturated Fatty Acids (n-3 PUFA) of marine origin (docosahexaenoic acid, DHA and eicosapentaenoic acid, EPA) have been shown to increase sensitivity of cell lines to anthracyclins or taxanes. Preclinical studies and a
Autor:
Dominique Berton-Rigaud, A.M. Savoye, Claire Garnier-Tixidre, François Goldwasser, Michel Fabbro, Jean-Philippe Spano, Jessica Berdougo-Tritz, Fernando Bazan, Jocelyne Provencal, N. Raban, Jérôme Alexandre, Fabien Brocard, Elsa Kalbacher, Frédéric Selle, Anne Patsouris, Virginie Pottier, Anne Mercier Blas, Isabelle Ray-Coquard, Claire Giraud, Vincent Launay-Vacher
Publikováno v:
Journal of Clinical Oncology. 37:5540-5540
5540 Background: The VENUS study reports on the efficacy/safety of bevacizumab (Bev) in patients (pts) treated in the real-life setting. Methods: In this multicentric observational ambispective VENUS study, all Pts were naive of any antiVEGF and rece
Autor:
Claire Jouffroy-Zeller, Marie Pierre Galais, Philippe Houyau, François Ghiringhelli, Marc Ychou, Anne Mercier Blas, René Adam, Thomas Aparicio, Laurent Mineur, Eric Assenat, Rosine Guimbaud, Antoine Adenis, Marion Chauvenet, Olivier Bouché, Faiza Khemissa, Simon Thezenas, Michel Rivoire, Eric Francois, Yves Becouarn, Franck Audemar
Publikováno v:
Journal of Clinical Oncology. 36:3535-3535
3535Background: pts with unresectable CRLM who respond to induction CT allowing curative-intent liver surgery have longer overall survival (OS) than pts who do not. Triplet (3-) or doublets (2-) CT...
Autor:
A-C. Hardy-Bessard, Alain Zannetti, Dominique Berton-Rigaud, Sophie Abadie-Lacourtoisie, A. Mercier-Blas, Benoit You, C. El Kouri, Michel Fabbro, J. Cretin, Gilles Freyer, Magali Provansal, Florence Joly, I.L. Ray-Coquard, Delphine Mollon, Oana Cojocarasu, Elsa Kalbacher
Publikováno v:
Annals of Oncology. 27:vi298
Autor:
P. Ardisson, M. Leheurteur, A-C. Hardy-Bessard, A. Mercier-Blas, Jérôme Dauba, A. Melis, A. Marti, A-M. Savoye, N. Barbier, E. Guardiola, Jérôme Meunier, Fabien Brocard, J. Grenier, N. Gane, R. Despax, Benoit You, J. Martin-Babau, Philippe Follana, C. Segura-Djezzar, Alain Lortholary
Publikováno v:
Annals of Oncology. 27:vi72
Autor:
Eric-Charles Antoine, Christelle Levy, Véronique Diéras, C. Le Maignan, J. Fleury, A. Mercier Blas, K. Joly, H. Simon, C.B. Villanueva, Mahasti Saghatchian
Publikováno v:
Acquis et limites en sénologie / Assets and limits in breast diseases ISBN: 9782817803951
Le bevacizumab (BEV) en premiere ligne associe au paclitaxel hebdomadaire, au docetaxel ou a une autre chimiotherapie ameliore significativement la survie sans progression (SSP) dans le cancer du sein metastatique (CSM) HER2-negatif, comme l’ont mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a215d6aac7652ee469bebadbb52c50a9
https://doi.org/10.1007/978-2-8178-0396-8_69
https://doi.org/10.1007/978-2-8178-0396-8_69